BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 23, 2012
View Archived Issues
Identification of biological markers to distinguish MCI from early-stage AD
Read More
DiaGenic announces improved blood test to detect Alzheimer's disease
Read More
Boehringer Ingelheim presents novel B-raf inhibitors
Read More
German researchers design new mGlu5 receptor modulators
Read More
Hong Kong researchers patent new agents for cancer
Read More
Sarepta's lead candidate for Marburg virus improves survival in primates
Read More
The Medicines Company patents new agents for thrombotic disorders
Read More
Phase III study of brivanib in HCC does not meet primary endpoint
Read More
Abbott offers overview of second quarter 2012
Read More
Sigma-Tau presents new HSP 90 inhibitors
Read More
New metabotropic glutamate receptor antagonists synthesized at Novartis
Read More
Novartis highlights achievements of second quarter 2012
Read More
Agilent enters biomarker discovery collaboration with Gachon University of Medicine and Science
Read More
FDA grants accelerated approval to Onyx' Kyprolis for injection in treatment of multiple myeloma
Read More
SEARCH trial shows no overall survival improvement with addition of Tarceva to Nexavar in HCC
Read More
EMA committee recommends approval of Adcetris for two lymphoma indications
Read More
Yichang Humanwell obtains license to remimazolam in China from Paion
Read More
Investigators develop novel ischemia-reperfusion model in human placenta
Read More
CHMP recommends conditional approval of crizotinib
Read More
Meiji Seika Pharma to discontinue development of schizophrenia drug candidate
Read More
Piramal receives clearance in India to conduct P-276 study
Read More
EB-101 shows efficacy in animal models of AD
Read More
EMA committee recommends approval of first gene therapy
Read More
Phase III study in breast cancer begins for novel micellar nanoparticles
Read More
FDA approves Afinitor in combination with exemestane in advanced breast cancer
Read More
Janssen submits application for new formulation of anti-HIV agent in Japan
Read More